Event News

Congratulations! De Ying Biotech’s Online Investor Conference Successfully Concluded

De Ying Biotech Co., Ltd.
was invited to participate in the online investor conference hosted by Hua Nan Securities Co., Ltd.

▶ Investor Conference Link

★ Features of De Ying’s Plant-based Drug R&D:

• Focused on cancer drug development, promoting innovation and breakthroughs.
• Developing solutions for hard-to-treat diseases to enhance clinical treatment effectiveness.
• Bringing significant breakthroughs and transformative changes to human health.

★ SR-100 Exclusive Patents (USA, Japan, Korea, Germany, New Zealand, Australia, and more)

• Patented functional health supplement ▶ Breakthrough in high human absorption.
• Patented functional skincare ▶ Anti-photo-carcinogenesis, photo-aging repair.
• SR-100 research published in internationally renowned dermatology journals.

▶ SR-100 Publication Link

★ Contact & Follow Us:

B2B Inquiries Email: service@geherbs.com.tw

Customer Service Hotline: 06-384-0890